Schedule 13G ownership disclosure
INFINITY PHARMACEUTICALS, INC.
Security class unavailable · CUSIP: 45665G303
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 913,460
- Percent of class
- 1.8000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000215457-17-003456
- Form type
- SC 13G
- Filer
- BlackRock Finance, Inc.
- CIK
- CIK 1364742
- Filed
- Jul 10, 2017
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership